Clearside Biomedical Inc (FRA:CLM)
€ 0.885 0.065 (7.93%) Market Cap: 69.14 Mil Enterprise Value: 47.25 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 65/100

Clearside Biomedical Inc at JMP Securities Life Sciences Conference Transcript

Jun 15, 2022 / 01:30PM GMT
Release Date Price: €1.26 (+2.20%)
Jon Wolleben
JMP Securities LLC - Analyst

Good morning, everybody. My name is Jon Wolleben, senior analyst here at JMP Securities, and we're pleased to kick off my day with Clearside Biomedical. And we have Tom Ciulla, Chief Medical and Development Officer, from Clearside joining us today. So thanks for coming, Tom.

Tom Ciulla
Clearside Biomedical, Inc. - Chief Medical Officer & CDO

Thanks for having me. I'm excited to be here.

Questions & Answers

Jon Wolleben
JMP Securities LLC - Analyst

So maybe to start, some people may not be as familiar with Clearside and the story. Can you give us the high-arching strategy that you have at the company?

Tom Ciulla
Clearside Biomedical, Inc. - Chief Medical Officer & CDO

Sure. So we specialize in suprachoroidal delivery of drugs. We have been working on suprachoroidal delivery for a number of years. Excited to say that, last October, we got our first asset approved; it's called XIPERE. It's being commercialized

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot